IDEXX LABORATORIES INC /DE - Common Stock (IDXX)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
80,841,255
Number of holders
788
Total 13F shares, excl. options
74,703,783
Shares change
-1,171,196
Total reported value, excl. options
$24,698,206,219
Value change
-$351,542,875
Put/Call ratio
89%
Number of buys
361
Number of sells
-349
Price
$330.16

Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2020

864 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2020.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 788 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 74,703,783 shares of 80,841,255 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9,420,300 shares), BlackRock Inc. (7,501,719 shares), Fundsmith LLP (4,240,711 shares), STATE STREET CORP (3,743,296 shares), BAMCO INC /NY/ (3,437,134 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,518,722 shares), BLAIR WILLIAM & CO/IL (1,551,674 shares), GEODE CAPITAL MANAGEMENT, LLC (1,390,604 shares), ALLIANCEBERNSTEIN L.P. (1,311,938 shares), and PRINCIPAL FINANCIAL GROUP INC (1,241,835 shares).
This table shows the top 788 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.